Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association
2017/10/23 by Mercedes R. Carnethon, Jia Pu, George Howard +9 · 35 citations
Medicine · #Cardiovascular Health and Risk Factors #Diabetes, Cardiovascular Risks, and Lipoproteins #Blood Pressure and Hypertension Studies
paper · pdf · doi:10.1161/cir.0000000000000534
Abstract
BACKGROUND AND PURPOSE: Population-wide reductions in cardiovascular disease incidence and mortality have not been shared equally by African Americans. The burden of cardiovascular disease in the African American community remains high and is a primary cause of disparities in life expectancy between African Americans and whites. The objectives of the present scientific statement are to describe cardiovascular health in African Americans and to highlight unique considerations for disease prevention and management. METHOD: The primary sources of information were identified with PubMed/Medline and online sources from the Centers for Disease Control and Prevention. RESULTS: The higher prevalence of traditional cardiovascular risk factors (eg, hypertension, diabetes mellitus, obesity, and atherosclerotic cardiovascular risk) underlies the relatively earlier age of onset of cardiovascular diseases among African Americans. Hypertension in particular is highly prevalent among African Americans and contributes directly to the notable disparities in stroke, heart failure, and peripheral artery disease among African Americans. Despite the availability of effective pharmacotherapies and indications for some tailored pharmacotherapies for African Americans (eg, heart failure medications), disease management is less effective among African Americans, yielding higher mortality. Explanations for these persistent disparities in cardiovascular disease are multifactorial and span from the individual level to the social environment. CONCLUSIONS: The strategies needed to promote equity in the cardiovascular health of African Americans require input from a broad set of stakeholders, including clinicians and researchers from across multiple disciplines.
Citations
Cited by
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
- Racial and Ethnic Disparities in Peripheral Artery Disease
- Estimation and Sensitivity Analysis for Causal Decomposition in Heath Disparity Research
- G1 and G2 ApolipoproteinL1 modulate macrophage inflammation and lipid accumulation through the polyamine pathway
- Rethinking Biva in obesity: systematic vector displacement across the adiposity spectrum
- Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study
- Racial-ethnic inequality in cardiovascular health in the United States: Does it mirror socioeconomic inequality?
- Diet and Prevention of Cardiovascular Disease and Cancer
- A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. [europepmc]
- Ethnic differences and comorbidities of 909 prurigo nodularis patients. [europepmc]
- Effect of Aspirin on Disability-free Survival in the Healthy Elderly. [europepmc]
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. [europepmc]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- Back to the Future: Achieving Health Equity Through Health Informatics and Digital Health. [europepmc]
- The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities. [europepmc]
- Discrimination and Hypertension Risk Among African Americans in the Jackson Heart Study. [europepmc]
- Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association. [europepmc]
- Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients. [europepmc]
- Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018. [europepmc]
- Racial and ethnic disparities in heart failure: current state and future directions. [europepmc]
- The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8. [europepmc]
- Ten things to know about ten cardiovascular disease risk factors. [europepmc]
- Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018. [europepmc]
- Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018. [europepmc]
- Historical redlining and cardiovascular health: The Multi-Ethnic Study of Atherosclerosis. [europepmc]
- Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. [europepmc]
- Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. [europepmc]
- A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities. [europepmc]
- Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020. [europepmc]
- 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. [europepmc]
- 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. [europepmc]
Related